Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis

mBio

Volumn 3, Issue 5, 2012, Pages

  Wiesner, Darin L ^a   Moskalenko, Oleksandr ^a   Corcoran, Jennifer M ^b   Mcdonald, Tami ^a   Rolfes, Melissa A ^b   Meya, David B ^b,c   Kajumbula, Henry ^c   Kambugu, Andrew ^b,c   Bohjanen, Paul R ^a,b   Knight, Joseph F ^b   Boulware, David R ^b   Nielsen, Kirsten ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868381599     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00196-12     Document Type: Article

References (68)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2011. World AIDS Day Report. Joint United Nations Programme onHIV/AIDS (U.N. AIDS), Geneva, Switzerland.
2. Park BJ, et al. 2009. Estimation of the current global burden of crypto-coccal meningitis among persons living with HIV/AIDS. AIDS 23: 525-530.
3. Boulware DR, et al. 2010. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med. 7:e1000384. http://dx.doi.org/10.1371/journal.pmed.1000384.
4. Bicanic T, et al. 2009. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J. Acquir. Immune Defic. Syndr. 51:130-134.
5. Perfect JR. 2005. Cryptococcus neoformans: a sugar-coated killer with designer genes. FEMS Immunol. Med. Microbiol. 45: 395-404.
6. Vecchiarelli A. 2000. Immunoregulation by capsular components of Cryptococcus neoformans. Med. Mycol. 38:407-417.
7. Kozel TR, Wilson MA, Pfrommer GS, Schlageter AM. 1989. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins. Infect. Immun. 57:1922-1927.
8. Kozel TR, Gotschlich EC. 1982. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J. Immunol. 129:1675-1680.
9. Beenhouwer DO, Shapiro S, Feldmesser M, Casadevall A, Scharff MD. 2001. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect. Immun. 69:6445-6455.
10. Siddiqui AA, et al. 2005. IFN-y at the site of infection determines rate of clearance of infection in cryptococcal meningitis. J. Immunol. 174: 1746-1750.
11. Hernandez Y, et al. 2005. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J. Immunol. 174:1027-1036.
12. Stenzel W, et al. 2009. IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis. Am. J. Pathol. 174:486-496.
13. Murphy K. 2011. Janeway's immunobiology, 8th ed. Garland Science, New York, NY.
14. Retini C, et al. 2001. Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans. Infect. Immun. 69:6064-6073.
15. Nallapareddy SR, Wenxiang H, Weinstock GM, Murray BE. 2005. Molecular characterization of a widespread, pathogenic, and antibiotic resistance-receptive Enterococcus faecalis lineage and dissemination of its putative pathogenicity island. J. Bacteriol. 187:5709-5718.
16. Ruiz-Garbajosa P, et al. 2006. Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in aback-ground of high rates of recombination. J. Clin. Microbiol. 44:2220-2228.
17. Dagerhamn J, et al. 2008. Determination of accessory gene patterns predicts the same relatedness among strains of Streptococcus pneumoniae as sequencing of housekeeping genes does and represents a novel approach in molecular epidemiology. J. Clin. Microbiol. 46:863-868.
18. Chang GH, et al. 2010. Sequence analysis of six enterovirus 71 strains with different virulences in humans. Virus Res. 151:66-73.
19. Ngamskulrungroj P, Serena C, Gilgado F, Malik R, Meyer W. 2011. Global VGIIa isolates are of comparable virulence to the major fatal Cryptococcus gattii Vancouver Island outbreak genotype. Clin. Microbiol. Infect. 17:251-258.
20. Harris JR, et al. 2011. Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin. Infect. Dis. 53: 1188-1195.
21. Casadevall A, Perfect JR. 1998. Cryptococcus neoformans. American Society for Microbiology, Washington, DC.
22. Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A. 2011. Cryptococcus: from human pathogen to model yeast. ASM Press, Washington, DC.
23. Meyer W, et al. 2009. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med. Mycol. 47: 561-570.
24. Litvintseva AP, Thakur R, Vilgalys R, Mitchell TG. 2006. Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana. Genetics 172:2223-2238.
25. Desnos-Ollivier M, et al. 2010. Mixed infections and in vivo evolution in the human fungal pathogen Cryptococcus neoformans. mBio. 1: e00091-10. http://dx.doi.org/10.1128/journal.pmed.00091-10.
26. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186: 1518-1530.
27. Staib F, Bethäuser G. 1968. Demonstration of Cryptococcus neoformans in the dust of a dovecote. Mykosen 11:619-624.
28. Miglia KJ, et al. 2011. Analyses of pediatric isolates of Cryptococcus neoformans from South Africa. J. Clin. Microbiol. 49:307-314.
29. Litvintseva AP, et al. 2011. Evidence that the human pathogenic fungus Cryptococcus neoformans var. grubii may have evolved in Africa. PLoS One 6:e19688.
30. Mandal P, Banerjee U, Casadevall A, Nosanchuk JD. 2005. Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in India. J. Clin. Microbiol. 43:4766-4772.
31. Haynes KA, et al. 1995. Involvement of multiple Cryptococcus neoformans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification of polymorphic DNA and DNA fingerprinting. J. Clin. Microbiol. 33: 99-102.
32. Litvintseva AP, et al. 2003. Evidence of sexual recombination among Cryptococcus neoformans serotype A isolates in sub-Saharan Africa. Eu-karyot. Cell 2:1162-1168.
33. Lin X, Nielsen K, Patel S, Heitman J. 2008. Impact of mating type, serotype, and ploidy on the virulence of Cryptococcus neoformans. Infect. Immun. 76:2923-2938.
34. Huffnagle GB, et al. 1996. Afferent phase production of TNF-a is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol. 157:4529-4536.
35. Olszewski MA, et al. 2000. The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J. Immunol. 165:6429-6436.
36. Kawakami K, Tohyama M, Xie Q, Saito A. 1996. IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin. Exp. Immunol. 104:208-214.
37. Huffnagle GB, Yates JL, Lipscomb MF. 1991. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J. Exp. Med. 173:793-800.
38. Flesch IE, Schwamberger G, Kaufmann SH. 1989. Fungicidal activity of IFN- y-activated macrophages: extracellular killing of Cryptococcus neoformans. J. Immunol. 142: 3219-3224.
39. Hoag KA, Lipscomb MF, Izzo AA, Street NE. 1997. IL-12 and IFN-y are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am. J. Respir. Cell Mol. Biol. 17: 733-739.
40. Hardison SE, et al. 2010. Pulmonary infection with an interferon-y-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am. J. Pathol. 176:774-785.
41. Jain AV, et al. 2009. Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection. Infect. Immun. 77:5389-5399.
42. Koguchi Y, Kawakami K. 2002. Cryptococcal infection and Th1-Th2 cytokine balance. Int. Rev. Immunol. 21:423-438.
43. Chayakulkeeree M, Perfect JR. 2006. Cryptococcosis. Infect. Dis. Clin. North Am. 20:507-544.
44. Kozel TR, Mastroianni RP. 1976. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis. Infect. Immun. 14:62-67.
45. Mitchell TG, Friedman L. 1972. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491-498.
46. Bulmer GS, Sans MD. 1968. Cryptococcus neoformans: inhibition of phagocytosis. J. Bacteriol. 95:5-8.
47. Yauch LE, Lam JS, Levitz SM. 2006. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog. 2:e120.
48. Retini C, Vecchiarelli A, Monari C, Bistoni F, Kozel TR. 1998. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes. Infect. Immun. 66: 664-669.
49. Mariano Andrade R, Monteiro Almeida G, Alexandre DosReis G, Alves Melo Bento C. 2003. Glucuronoxylomannan of Cryptococcus neoformans exacerbates in vitro yeast cell growth by interleukin 10-dependent inhibition of CD4+ T lymphocyte responses. Cell. Immunol. 222:116-125.
50. Kawakami K, et al. 1999. Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with IFNy-inducing cytokines. Cell. Immunol. 197:55-61.
51. Müller U, et al. 2012. Lack of IL-4 receptor expression on T helper cells reduces T helper 2 cell polyfunctionality and confers resistance in allergic bronchopulmonary mycosis. Mucosal Immunol. 5:299-310.
52. Wiesner DL, Boulware DR. 2011. Cryptococcus-related immune recon-stitution inflammatory syndrome (IRIS): pathogenesis and its clinical implications. Curr. Fungal Infect. Rep. 5:252-261.
53. Jarvis JN, et al. 2012. Adjunctive IFNy immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial. AIDS 26:1105-1113.
54. Kambugu A, et al. 2008. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin. Infect. Dis. 46:1694-1701.
55. Boulware DR, et al. 2010. Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. J. Infect. Dis. 202:962-970.
56. Nielsen K, et al. 2003. Sexual cycle of Cryptococcus neoformans var. grubii and virulence ofcongenicaand a isolates. Infect. Immun. 71:4831-4841.
57. Toffaletti DL, Rude TH, Johnson SA, Durack DT, Perfect JR. 1993. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175:1405-1411.
58. Meyer W, et al. 2003. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg. Infect. Dis. 9:189-195.
59. Kwon-Chung KJ, Edman JC, Wickes BL. 1992. Genetic association of mating types and virulence in Cryptococcus neoformans. Infect. Immun. 60:602-605.
60. Varma A, Kwon-Chung KJ. 1998. Construction of stable episomes in Cryptococcus neoformans. Curr. Genet. 34:60-66.
61. Fraser JA, et al. 2005. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 437:1360-1364.
62. Gillum AM, Tsay EY, Kirsch DR. 1984. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 andE. colipyrF mutations. Mol. Gen. Genet. 198:179-182.
63. Christensen WB. 1946. Urea decomposition as a means of differentiating Proteus and Paracolon cultures from each other and from Salmonella and Shigella types. J. Bacteriol. 52:461-466.
64. Klein KR, et al. 2009. Identification of Cryptococcus gattii by use of l-canavanine glycine bromothymol blue medium and DNA sequencing. J. Clin. Microbiol. 47:3669-3672.
65. Liu D, Coloe S, Baird R, Pederson J. 2000. Rapid mini-preparation of fungal DNA for PCR. J. Clin. Microbiol. 38:471.
66. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
67. Wang Y, Aisen P, Casadevall A. 1995. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect. Immun. 63:3131-3136.
68. Lengeler KB, Cox GM, Heitman J. 2001. Serotype AD strains of Cryptococcus neoformans are diploid or aneuploid and are heterozygous at the mating-type locus. Infect. Immun. 69:115-122.